Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Children’s debit card provider Greenlight is valued at $1.2bn after raising $215m in funding from a host of investors, though none of its corporate backers participated this time.

Cancer drug developer Silverback has secured $211m to date from investors including BMS, Celgene and Alexandria Real Estate Equities.

Xingyun has picked up $200m in a series C round co-led by Taikang Insurance, Shanghai United Media Group and Highlight Capital, while GLP and C&D Group also invested.

Avery Dennison and Valo Ventures both invested to lift recycling service provider RoadRunner's series C total to $38.9m.

Existing investors Johnson & Johnson and WuXi AppTec have returned to take part in the neurological drug developer’s latest funding.

Group 42 has joined existing shareholder BP Ventures to co-lead a series C round for Caltech and Nasa spinout Beyond Limits, with $113m already closed and another $20m committed.

Group 42 and BP Ventures have co-led a series C round for Caltech and Nasa spinout Beyond Limits, with $113m already closed.

Backed by Shanghai Fudan University previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.